IMAGENE AI
Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy. Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for... cancer patients. Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.
IMAGENE AI
Industry:
Artificial Intelligence Biotechnology Health Care Health Diagnostics
Founded:
2020-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.imagene-ai.com
Total Employee:
11+
Status:
Active
Total Funding:
21.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
DermAI
DermAI focuses on leveraging AI to improve skincare by offering online skin consultations.
E-Health Now LLC
We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally, on a B2B model.
EQL
EQL specializes in the fields of AI, machine learning, physiotherapy, insurance, heathtech, and digital health.
Quantason
Quantason develops bi-modal US/IDUS™ platform technology for diagnostic imaging and active screening.
Current Employees Featured
Shahar Porat Co-Founder & CTO @ Imagene AI
Co-Founder & CTO
2020-01-01
Dean Bitan Co-founder & CEO @ Imagene AI
Co-founder & CEO
2020-01-01
Jonathan Zalach Co-Founder & Chief Data Scientist @ Imagene AI
Co-Founder & Chief Data Scientist
2020-04-01
Founder
Investors List
Eyal Gura
Eyal Gura investment in Series A - Imagene AI
David Agus
David Agus investment in Series A - Imagene AI
Blumberg Capital
Blumberg Capital investment in Seed Round - Imagene AI
Larry Ellison
Larry Ellison investment in Series A - Imagene AI
Official Site Inspections
http://www.imagene-ai.com Semrush global rank: 9.53 M Semrush visits lastest month: 141
- Host name: server-18-160-46-25.iad55.r.cloudfront.net
- IP address: 18.160.46.25
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Imagene AI"
Imagene AI - Crunchbase Company Profile & Funding
Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy. Our mission at Imagene is …See details»
About Us - Imagene
Send a request email to lab@imagene-ai.com. Provide your name, work email address, and phone number in the email. We will contact you to register an account for the online lab portal. You will receive secured log-in details and a …See details»
Contact Us - Imagene AI
Info@imagene-ai.com; 252 NW 29th St., No.9 Miami FL 33127, USA; 2415 E Camelback Rd, Phoenix, AZ 85016 (Lab) 17 Yizhak Sade St., Tel Aviv, Israel; Full Name Title Work Email …See details»
Imagene - LinkedIn
Imagene is a pioneering company in AI-based precision oncology, dedicated to decoding cancer using biopsy images. Our mission is to unlock the power of Oncology Intelligence to transform cancer ...See details»
Imagene - Oncology Intelligence
"The ability to use Imagene's AI technology under research is a game-changer. It allowed us to bypass the usual lengthy waiting period associated with comprehensive genomic profiling. This technology is revolutionizing the way …See details»
Imagene AI Information - RocketReach
Imagene is a pioneering company in AI-based precision oncology, dedicated to decoding cancer using biopsy images. Our mission is to unlock the power of Oncology Intelligence to transform …See details»
Oracle co-founder Larry Ellison leads $21.5m round for Imagene AI
May 3, 2022 Israeli cancer diagnosis start-up Imagene AI has raised $21.5 million in first-round financing for its cancer diagnosis platform-based digitised imaging of biopsy samples. The Series A – led by ...See details»
Imagene AI Company Profile | Management and Employees List
Find contact information for Imagene AI. Learn about their Research & Development, Business Services market share, competitors, and Imagene AI's email format. Company Overview. …See details»
Imagene AI - Contacts, Employees, Board Members, Advisors
Organization. Imagene AI . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
Imagene AI - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 2, 2022: Seed Round - …See details»
Imagene 2025 Company Profile: Valuation, Funding
David Agus, Eyal Gura, Lawrence Ellison, Blumberg Capital, and Katao Venture Partners are 5 of 6 investors who have invested in Imagene. Who are Imagene’s competitors? PreciseDx , Notable Labs , Biocept , Inspirata , and Strata …See details»
Imagene - Company Profile - Tracxn
Dec 4, 2024 Imagene - Provider of an AI-based cancer diagnosis and precision medicine planning software for healthcare providers. Raised a total funding of $21.5M over 3 rounds …See details»
Imagene AI - Overview, News & Similar companies | ZoomInfo.com
Aug 15, 2023 View Imagene AI (www.imagene-ai.com) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Imagene taps Oracle Cloud Infrastructure in fight against cancer
Oct 3, 2024 Dean Bitan, co-founder and CEO of Imagene AI, a pioneer in AI-based precision oncology, is a software engineer by training. ... Northwestern, and Hoag in the United States, …See details»
Imagene AI - Craft
Imagene AI is a company that develops AI diagnostic technologies. Its molecular and micro-environment intelligence platform uses a digitized biopsy image to deliver real-time molecular …See details»
Imagene AI Company Profile: Overview and Full News Analysis
Imagene AI, based in Tel Aviv, is a company that leverages artificial intelligence to provide immediate oncology intelligence through the profiling of cancer biomarkers from biopsy …See details»
Imagene AI (אימג'ין איי.אי) | Digital Health Startup Profiles ...
Imagene AI (אימג'ין איי.אי) is a Israel based HealthTech company, focused on Medical Imaging. Discover digital health profiles with HealthTech Alpha. ... Imagene overcomes economical, …See details»
Imagene Partners with Oracle to Launch CanvOI on Oracle Cloud ...
Sep 10, 2024 Oracle and Imagene, a pioneer in AI-based precision oncology, today announced CanvOI, a state-of-the-art pan-cancer foundation model designed to facilitate innovative research and development in the digital pathology and oncology space. Running on Oracle Cloud Infrastructure (OCI), CanvOI captures the complex features and patterns within biopsy images, …See details»
Israeli Startup Imagene AI Secures $21.5 Million for Precision …
Jan 16, 2025 Imagene AI announced it raised $21.5 million, comprising $3 million in seed funding led by Blumberg Capital and an $18.5 million Series A round led by renowned technology-driven cancer medicine investors Larry Ellison, Dr. David Agus, and AI imaging space pioneer Eyal Gura.. Using only a digitized biopsy image, Imagene’s AI diagnostic technology delivers …See details»
Imagene - Crunchbase Company Profile & Funding
Organization. Imagene . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Imagene provides room temperature storage solution for nucleic acids, …See details»